Overview
Updated 06/22/2021
DC additional COVID paid leave (Expanded under FFCRA)
Items to add to Avionte Standard Sick Leave Accruals
URL: https://avionteclassicsupport.zendesk.com/hc/en-us/articles/360045857833-sick-leave-overview#AvionteStandardSickLeave
- Where – Washington D.C.
- Accrual Plan – Sick Leave_DC_COVID19
- Summary
- Accrued Sick and Safe Leave Act (ASSLA) amended to require employers with between 50 and 499 employees (other than “health care providers” as defined in the law) to provide eligible employees with up to 2 weeks (80 hours) of paid “public health emergency leave” at full pay for any reason for which paid leave is available under the federal Families First Coronavirus Response Act (FFCRA).
- Eligible Employees. An employee is eligible to take Declared Emergency Leave if the employee commenced work for the employer at least 15 days before the request for leave. This is different from other ASSLA leave, which begins accruing immediately but is accessible only after 90 days of employment.
- Interaction With Other Leave Availability. Employers may require that an employee exhaust any available leave under federal (can be used concurrently with FFCRA) or D.C. law or an employer’s own policies prior to using Declared Emergency Leave.
- Notes – D.C. recently passed some additional COVID Paid leave that is separate from our current FFCRA offerings. This is currently in effect. Thinking it is best to create an additional transaction type & accrual for it. Outline below:
Items to add to Simplified Sick Leave Plans
URL: https://avionteclassicsupport.zendesk.com/hc/en-us/articles/360045857833-sick-leave-overview#SimplifiedPlans
- State – Washington D.C.
- City – Washington D.C
- Accrual Plan – Sick Leave_DC_COVID19
- Effective Date – 04/10/2020
- Hours to Accrue 1 hour – N/A – Plan is preloaded with 80 hours
- Days before use – Must work for the employer for 15 days before use.
- Gap Days – N/A
- Max Hours Use in 1 year – 80
- Max Accrual Balance – 80
- Yearly Limit – 80
- Allowed Carry Over Hours – Unlimited
Comments
0 comments
Please sign in to leave a comment.